1 |
Greenhalgh D, Al‐rashidi N. Modeling the spread of hepatitis C virus amongst people who inject drugs. Engineering Reports. [DOI: 10.1002/eng2.12503] [Reference Citation Analysis]
|
2 |
Harney BL, Whitton B, Paige E, Brereton R, Weiss R, Membrey D, Wade AJ, Iser D, Kemp W, Roberts SK, Spelman T, Sacks-Davis R, Hellard ME, Doyle JS. A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia. Liver Int 2021. [PMID: 34821021 DOI: 10.1111/liv.15107] [Reference Citation Analysis]
|
3 |
Lee Wilkinson A, Pedrana A, Traeger MW, Asselin J, El-hayek C, Nguyen L, Polkinghorne V, Doyle JS, Thompson AJ, Howell J, Scott N, Dimech W, Guy R, Hellard M. Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019. Epidemiol Infect 2022;150. [DOI: 10.1017/s0950268821002624] [Reference Citation Analysis]
|
4 |
Rogers ME, Balistreri WF. Cascade of care for children and adolescents with chronic hepatitis C. World J Gastroenterol 2021; 27(12): 1117-1131 [PMID: 33828389 DOI: 10.3748/wjg.v27.i12.1117] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
5 |
Wilkinson AL, van Santen DK, Traeger MW, Sacks-Davis R, Asselin J, Scott N, Harney BL, Doyle JS, El-Hayek C, Howell J, Bramwell F, McManus H, Donovan B, Stoové M, Hellard M, Pedrana A. Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020. Int J Drug Policy 2022;103:103655. [PMID: 35349964 DOI: 10.1016/j.drugpo.2022.103655] [Reference Citation Analysis]
|